Osaic Holdings’s Jasper Therapeutics JSPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$26.6K Hold
1,528
– – ﹤0.01% 5963
2026
Q2
$19.3K Buy
1,528
+166
+12% +$3.73K ﹤0.01% 6199
2026
Q1
$35.8K Hold
1,362
– – ﹤0.01% 5597
2025
Q4
$74.8K Sell
1,362
-28
-2% -$1.69K ﹤0.01% 4956
2025
Q3
$100K Buy
1,390
+1,362
+4,864% +$124K ﹤0.01% 4785
2025
Q2
$4.64K Hold
28
– – ﹤0.01% 6582
2025
Q1
$3.6K Hold
28
– – ﹤0.01% 6349
2024
Q4
$17.9K Hold
28
– – ﹤0.01% 5421
2024
Q3
$15.7K Hold
28
– – ﹤0.01% 5520
2024
Q2
$19K Buy
+28
New +$20.1K ﹤0.01% 5382

Other funds holding JSPR

Osaic Holdings's JSPR Position: Q3 2026 in Review

Osaic Holdings held its Jasper Therapeutics (JSPR) position steady in Q3 2026 at 1,528 shares worth $26.6K. The position accounts for ﹤0.01% of the portfolio, ranked #5963.

Osaic Holdings first reported a position in JSPR in Q2 2024 and has held it in 10 quarters since. The position peaked at $100K in Q3 2025. 50 funds tracked by Wall St. Rank hold JSPR as of Q3 2026.

  • Osaic Holdings held 1,528 shares of Jasper Therapeutics worth $26.6K as of Q3 2026.
  • Osaic Holdings left its Jasper Therapeutics share count unchanged in Q3 2026.
  • Jasper Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q3 2026, its #5963 holding.
  • Osaic Holdings first reported a position in Jasper Therapeutics in Q2 2024 and has held it in 10 quarters since.
  • Osaic Holdings's Jasper Therapeutics position peaked at $100K in Q3 2025.
  • 50 funds tracked by Wall St. Rank held Jasper Therapeutics as of Q3 2026.

Based on Osaic Holdings's 13F filing for Q3 2026, filed 12 Nov 2026.